Results of a Phase II trial of tumor lysate-pulsed dendritic cell vaccination for malignant glioma

被引：1
|
作者：
Yu, JS
Black, KL
Liu, GT
Wheeler, CJ
Wagenberg, M
Das, A
Mindlin, E
Chu, RM
Luptrawan, A
Badruddoja, MA
机构：
来源：
NEUROSURGERY | 2005年 / 57卷 / 02期
关键词：
D O I：
10.1093/neurosurgery/57.2.409b
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
843
引用
收藏
页码：409 / 410
页数：2
相关论文
共 50 条
  • [1] Results of a phase II trial of tumor lysate-pulsed dendritic cell vaccination for patients with malignant brain tumors
    Yu, John S.
    Liu, Gentao
    Wagenberg, Mia
    Mindlin, Elina
    Luptrawan, Anne
    Wheeler, Chris J.
    Black, Keith L.
    JOURNAL OF NEUROSURGERY, 2007, 106 (04) : A744 - A744
  • [2] Vaccination of recurrent glioma patients with tumour lysate-pulsed dendritic cells elicits immune responses: results of a clinical phase I/II trial
    R Yamanaka
    T Abe
    N Yajima
    N Tsuchiya
    J Homma
    T Kobayashi
    M Narita
    M Takahashi
    R Tanaka
    British Journal of Cancer, 2003, 89 : 1172 - 1179
  • [3] Vaccination of recurrent glioma patients with tumor lysate-pulsed dendritic cells elicits immune responses: Results of a clinical phase 1/2 trial
    Homa, J
    Yamanaka, R
    Abe, T
    Narita, M
    Takahashi, M
    Tanaka, R
    NEURO-ONCOLOGY, 2005, 7 (03) : 368 - 369
  • [4] Vaccination of patients with malignant glioma with tumor lysate-pulsed dendritic cells producing antigen-specific cytotoxicity
    Yu, JS
    Wheeler, CJ
    Liu, GT
    Ying, H
    Yong, WH
    Das, A
    Black, K
    JOURNAL OF NEUROSURGERY, 2004, 100 (04) : 772 - 772
  • [5] Vaccination of recurrent glioma patients with tumour lysate-pulsed dendritic cells elicits immune responses: results of a clinical phase I/II trial
    Yamanaka, R
    Abe, T
    Yajima, N
    Tsuchiya, N
    Tsuchiya, N
    Homma, J
    Kobayashi, T
    Narita, M
    Takahashi, M
    Tanaka, R
    BRITISH JOURNAL OF CANCER, 2003, 89 (07) : 1172 - 1179
  • [6] Vaccination of recurrent glioma patients with tumour lysate-pulsed dendritic cells elicits immune responses: Results of a clinical phase I/II trial
    Yamanaka, R
    Homma, J
    Yajima, N
    Tsuchiya, N
    Tanaka, R
    MOLECULAR THERAPY, 2004, 9 : S98 - S98
  • [7] Genetic signature of malignant glioma is associated with responsiveness to autologous tumor lysate-pulsed dendritic cell vaccination plus TLR agonists
    Prins, Robert M.
    Soto, Horacio
    Konkankit, Vera
    Yong, William H.
    Nelson, Stanley F.
    Liau, Linda M.
    CANCER RESEARCH, 2010, 70
  • [8] Vaccination with tumor cell lysate-pulsed dendritic cells augments the effect of IFN-β gene therapy for malignant glioma in an experimental mouse intracranial glioma
    Saito, R
    Mizuno, M
    Nakahara, N
    Tsuno, T
    Kumabe, T
    Yoshimoto, T
    Yoshida, J
    INTERNATIONAL JOURNAL OF CANCER, 2004, 111 (05) : 777 - 782
  • [9] Vaccination of advanced hepatocellular carcinoma patients with tumor lysate-pulsed dendritic cells - A clinical trial
    Lee, WC
    Wang, HC
    Hung, CF
    Huang, PF
    Lia, CR
    Chen, MF
    JOURNAL OF IMMUNOTHERAPY, 2005, 28 (05) : 496 - 504
  • [10] A phase I trial of tumor lysate-pulsed dendritic cells in the treatment of advanced cancer
    Chang, AE
    Redman, BG
    Whitfield, JR
    Nickoloff, BJ
    Braun, TM
    Lee, PP
    Geiger, JD
    Mulé, JJ
    CLINICAL CANCER RESEARCH, 2002, 8 (04) : 1021 - 1032
12345